Phase 4 Parkinson Clinical Trials
16 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–16 of 16 trials
Recruiting
Phase 4
Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
Parkinson Disease
Emory University80 enrolled2 locationsNCT06234995
Recruiting
Phase 4
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
InsomniaParkinson's DiseaseMotor Disorder
YangPan44 enrolled1 locationNCT07384429
Recruiting
Phase 4
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
Dementia With Lewy BodiesParkinson Disease Dementia
Virginia Commonwealth University120 enrolled1 locationNCT07284290
Recruiting
Phase 4
Clozapine-related Immunodeficiency in Parkinsons Disease
ImmunodeficiencyPsychosisParkinson's Disease (PD)+1 more
Centre Hospitalier Universitaire, Amiens24 enrolled1 locationNCT06634641
Recruiting
Phase 4
Comparing Antipsychotic Medications in LBD Over Time
Dementia With Lewy BodiesParkinson's Disease Psychosis
The University of Texas Health Science Center at San Antonio94 enrolled2 locationsNCT05590637
Recruiting
Phase 4
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Parkinson Disease
Impax Laboratories, LLC220 enrolled27 locationsNCT06765668
Recruiting
Phase 4
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
Parkinson Disease
The Cleveland Clinic22 enrolled1 locationNCT07138560
Recruiting
Phase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Parkinson's Disease Psychosis
VA Office of Research and Development358 enrolled24 locationsNCT04373317
Recruiting
Phase 4
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
Parkinson DiseaseNeurodegenerative DiseasesParkinson Disease Psychosis
Vanderbilt University Medical Center75 enrolled1 locationNCT05357612
Recruiting
Phase 4
Imaging Biomarkers of FOG Response to DBS
Deep Brain StimulationFreezing of Gait Symptoms in Parkinson's Disease
Medical University of South Carolina54 enrolled1 locationNCT06951906
Recruiting
Phase 4
Personalized Real-Time DBS and PD Mechanisms
Parkinson Disease
David Escobar25 enrolled1 locationNCT06013956
Recruiting
Phase 4
Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving RBD with Parkinson's Disease
Movement DisordersParkinson DiseaseGut Microbiomes+3 more
Beijing Friendship Hospital120 enrolled1 locationNCT06710574
Recruiting
Phase 4
DBS and Levodopa for Treating Freezing of Gait in Parkinson's Disease
Parkinson DiseaseFreezing of Gait
IRCCS Istituto delle Scienze Neurologiche di Bologna20 enrolled1 locationNCT06316232
Recruiting
Phase 4
The effect of a GLP-1 agonist in patients with a dual diagnosis of Parkinson's Disease and Type 2 Diabetes Mellitus
Type 2 Diabetes MellitusParkinson's Disease
St Vincent's Health Network12 enrolled1 locationACTRN12620000627954
Recruiting
Phase 4
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
SchizophreniaTobacco SmokingParkinsonism+2 more
Corporal Michael J. Crescenz VA Medical Center10 enrolled1 locationNCT03495024
Not Yet Recruiting
Phase 4
Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease
InsomniaParkinson's Disease
University of Queensland44 enrolled1 locationACTRN12617001103358